Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Obstructive sleep apnea stories

Nov 14, 2026

Eli Lilly releases new obesity drug clinical trial data at ObesityWeek

Eli Lilly released new clinical trial data for its obesity drugs at the ObesityWeek 2026 medical conference, showing weight loss benefits, though full results have not yet been published.

Nov 14, 2026·2 sources
00

Top claims

  • ▪Adolescents taking Zepbound in Eli Lilly's SURMOUNT-ADOLESCENTS trial reported improvements in weight-related quality of life, including physical comfort and body esteem
  • ▪Eli Lilly plans to submit its late-stage trial results for Foundayo to the U.S. FDA by the end of 2026 for U.S. approval to treat moderate-to-severe obstructive sleep apnea
  • ▪In Eli Lilly's trial, Foundayo reduced the average apnea-hypopnea index at 52 weeks by 21.1 events per hour in patients not on positive airway pressure therapy compared to 4.8 for placebo and 18.3 with it compared to 5.5 for placebo

Subtopics

Blood sugar & insulin1Clinical trials1Eli Lilly1Foundao1Obesity treatment1Sleep apnea1Weight loss drugs1Weight management1Zepbound1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories